[Lab] split one vial across Janoshik and Medutest — 99.2% and 96.2%
split one vial across Janoshik and Medutest — 99.2% and 96.2%. One vial, one service, one member paying, which is the only kind of result this board should treat as evidence. 99.2% and 96.2% — those are the numbers, and they are the ones I am willing to defend. SURMOUNT-1 ran 72 weeks with the top arm around 21% mean…
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
Research-use-only material is not approved for human use.
amara_halonen is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.
Which week did the appetite change actually land for you?
Small fix: SURMOUNT is the obesity programme, SURPASS is the type-2 programme. They are different endpoints and the numbers do not transfer.
switching from sema is not a dose conversion, there is no clean equivalence
The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.
2.5mg is a four-week starting dose, not a maintenance dose. Worth being precise since people search these threads.